Targeted Dry Eye Therapies

Name: Targeted Dry Eye Therapies
Brand: Boling Vision Center

At Boling Vision Center's Cornea & Ocular Surface Center, we go beyond artificial tears and one-size-fits-all drop regimens to offer a full range of targeted, evidence-based therapies designed to address the specific mechanisms driving each guest's dry eye disease.

Treatment That Actually Gets to the Source

For too long, dry eye has been managed rather than treated: artificial tears handed out at appointments, symptoms temporarily quieted, and the underlying problem left unaddressed. At Boling Vision Center's Cornea & Ocular Surface Center, we take a fundamentally different approach. Using advanced diagnostics to identify the specific drivers of each guest's dry eye, we build targeted, layered treatment plans designed to produce lasting improvement rather than temporary relief.

Schedule a dry eye evaluation at any of our four Northern Indiana locations and find out what targeted therapy can actually do for you.

Why Targeted Treatment Matters

Dry eye disease has multiple potential causes, and the treatment that works for one guest may do little for another. Meibomian gland dysfunction, aqueous deficiency, ocular surface inflammation, blepharitis, and neurotrophic changes each require a different therapeutic approach. Prescribing the same drops to every guest with dry eye symptoms is the equivalent of treating every headache the same way, regardless of its cause.

At Boling Vision Center, every dry eye treatment plan begins with a comprehensive evaluation that identifies which mechanisms are driving the condition. That diagnostic foundation is what makes targeted therapy possible, and it's what separates meaningful, sustained improvement from the cycle of temporary relief that many dry eye sufferers know all too well.

Our Targeted Dry Eye Therapies

The following therapies represent the core of our targeted dry eye treatment approach. Many guests benefit from a combination of these options, and treatment plans are adjusted over time as the ocular surface responds and heals.

Prescription Anti-Inflammatory Therapy

Inflammation is a central driver of dry eye disease for many guests, perpetuating a cycle of surface damage, gland dysfunction, and tear film instability. Prescription anti-inflammatory eye drops, including cyclosporine and lifitegrast formulations, work at the cellular level to interrupt that cycle and help restore healthier ocular surface function over time.

Unlike artificial tears, which address symptoms temporarily, prescription anti-inflammatory therapy targets the underlying disease process. Results typically build over one to three months of consistent use, and many guests experience significant improvement in both comfort and vision quality with sustained treatment.

Meibomian Gland Expression and Thermal Treatment

Meibomian gland dysfunction is the leading cause of evaporative dry eye, and restoring gland function requires more than drops can provide. In-office thermal treatments apply controlled heat to the eyelids to liquefy thickened meibomian gland secretions, followed by expression to clear blocked glands and restore the flow of the lipid layer essential to tear film stability.

These treatments can produce meaningful, lasting improvement in gland function and dry eye symptoms, with results that extend well beyond what any topical therapy alone can achieve. For guests with significant MGD, gland-directed treatment is often the single most impactful intervention in their care plan.

Intense Pulsed Light (IPL) Therapy

IPL therapy uses precisely calibrated pulses of light to target the abnormal blood vessels around the eyelid margins that contribute to meibomian gland inflammation and dysfunction. Originally developed for dermatological use, IPL has become an important tool in dry eye management for guests with evaporative dry eye, particularly those with ocular rosacea or significant lid margin disease.

IPL is performed as a series of in-office treatments and is well-tolerated by most guests. Beyond its effects on the meibomian glands, it reduces the inflammatory mediators that contribute to the broader ocular surface disease cycle, making it a valuable component of a comprehensive dry eye treatment plan for the right candidates.

Neurostimulation

For guests with aqueous-deficient dry eye, stimulating the body's natural tear production can be a highly effective approach. Neurostimulation devices work by activating the nasal-lacrimal reflex pathway, prompting the lacrimal glands to produce natural tears on demand. This approach is particularly useful for guests who haven't responded adequately to topical therapies and prefer a drug-free option for managing their condition.

Punctal Occlusion

The puncta are the small drainage openings in the inner corner of each eyelid through which tears drain away from the ocular surface. In guests with aqueous-deficient dry eye, closing one or more of these openings helps retain the tears that are being produced, keeping the ocular surface better lubricated for longer.

Punctal occlusion can be performed temporarily using dissolvable plugs to assess response before committing to a more permanent approach, or with semi-permanent silicone plugs for guests who respond well. It is a simple, well-tolerated procedure that can provide meaningful relief, particularly as part of a broader treatment plan.

Autologous Serum Eye Drops

For guests with severe dry eye that hasn't responded adequately to conventional therapies, autologous serum eye drops offer a uniquely personalized option. Prepared from the guest's own blood, these drops contain growth factors, vitamins, and proteins that closely mimic the composition of natural tears and actively support ocular surface healing.

Autologous serum drops are particularly beneficial for guests with neurotrophic dry eye, ocular surface disease associated with autoimmune conditions, or persistent epithelial defects where standard lubricants provide insufficient support. They represent one of the more advanced options in our dry eye toolkit and are reserved for cases where the clinical picture warrants them.

Scleral Lenses

For guests with moderate to severe dry eye, particularly those whose vision is also affected by surface irregularity, scleral contact lenses can be transformative. By vaulting over the entire corneal surface and creating a fluid reservoir between the lens and the eye, sclerals provide continuous hydration and optical correction throughout the day.

Scleral lenses are not a cure for dry eye, but for the right guest, they can dramatically improve both comfort and visual quality while other therapies work on the underlying disease. They are an important part of the toolkit for guests whose dry eye hasn't responded sufficiently to other interventions.

Eyelid Hygiene and Blepharitis Management

For guests with blepharitis or significant lid margin disease contributing to their dry eye, targeted eyelid hygiene treatments are a foundational part of the care plan. In-office treatments can address bacterial biofilm and Demodex infestation at the lid margins, reducing the chronic low-grade inflammation that drives meibomian gland dysfunction and tear film instability.

Paired with appropriate at-home maintenance, eyelid hygiene interventions produce a cleaner, healthier lid margin environment that supports the effectiveness of other dry eye therapies.

Very positive experience, as always!

Brenda Johnson

Building Your Treatment Plan

No two dry eye presentations are identical, and no single therapy addresses every aspect of the condition. At Boling Vision Center, we approach dry eye treatment as an evolving process: starting with the therapies most likely to address the primary drivers identified in your evaluation, monitoring your response, and adjusting the plan over time.

Most guests see meaningful improvement within the first few months of targeted treatment. Some conditions, particularly those involving meibomian gland damage or chronic inflammation, require longer-term management, and we stay engaged throughout that process rather than simply prescribing and stepping back.

Schedule A Consultation

Why Choose Boling Vision Center?

Boling Vision Center's Cornea & Ocular Surface Center brings together the diagnostic tools, the full range of targeted therapies, and the clinical expertise to manage dry eye at every level of severity. We treat dry eye as the medical condition it is, with the same precision and attentiveness we bring to every other aspect of eye care.

With four Northern Indiana locations and a team that genuinely invests in long-term outcomes, we're the practice guests with difficult dry eye trust to get it right. Amazing happens here.

Frequently Asked Questions Targeted Dry Eye Therapies

How do I know which dry eye therapy is right for me?

The right therapy depends on what's driving your dry eye, and that's determined through a comprehensive evaluation rather than a one-size-fits-all approach. After assessing your tear film, meibomian gland function, ocular surface health, and relevant history, your provider will recommend the therapies most likely to address your specific situation and discuss what each involves.

How long before I see results from targeted dry eye treatment?

It depends on the therapy and the severity of the condition. Some treatments, like in-office meibomian gland procedures, can produce noticeable improvement within a few weeks. Prescription anti-inflammatory drops typically take one to three months to show their full benefit. The key is consistency; dry eye treatment rewards patience and adherence, and results compound over time with a well-managed plan.

Do I have to stop using artificial tears if I start prescription therapy?

Not necessarily. Preservative-free artificial tears are a useful supportive tool and can be used alongside prescription therapies and in-office treatments. Your provider will advise on the most appropriate lubricating drops for your situation and how to incorporate them into your broader treatment plan.

Are in-office dry eye treatments covered by insurance?

Coverage varies depending on your insurance plan and the specific treatment. Some prescription therapies are covered with prior authorization; in-office procedures like IPL are often considered elective and may not be covered. Our team will help you understand your coverage options and discuss the investment involved in any recommended treatment before you proceed.

Can dry eye come back after successful treatment?

Dry eye disease is often chronic in nature, meaning that even after significant improvement, ongoing maintenance is typically needed to sustain results. The goal of targeted treatment is not just to relieve current symptoms but to restore the ocular surface to a healthier baseline that's easier to maintain long term. Many guests find that after an initial course of active treatment, a simpler maintenance regimen is sufficient to keep symptoms well controlled.